Navigation Links
Synutra International, Inc. Amends August 2005 Current Report on Form 8-K and Annual Report on Form 10-K for the Fiscal Year Ended March 31, 2007
Date:1/15/2008

QINGDAO, China and ROCKVILLE, Md., Jan. 15 /Xinhua-PRNewswire/ -- Synutra International, Inc. (Nasdaq: SYUT; ''Synutra''), one of China's leading manufacturers of dairy-based nutritional products for infants, children and adults, today filed amendments to its Current Report on Form 8-K filed on August 22, 2005 and its Annual Report on Form 10-K for the fiscal year ended March 31, 2007 with the U.S. Securities and Exchange Commission. As explained in the Forms 8-K and 10-K, the amendments are the result of certain deficiencies and errors in Synutra's financial statements identified during its ongoing assessment process to improve the effectiveness of its disclosure controls and procedures and internal control over financial reporting.

Synutra previously concluded that the audited consolidated Balance Sheets, Income Statements and Cash Flow Statements as of and for the calendar years ended December 31, 2003 and 2004 and unaudited consolidated Balance Sheets, Income Statements and Cash Flow Statements as of and for the three and six months ended June 30, 2004 and 2005 of its wholly owned subsidiary, Synutra Inc. (''Synutra Illinois''), should no longer be relied upon because of errors in such financial statements. The Current Report on Form 8-K filed today restates Synutra Illinois' financial statements to (i) reclassify certain other income as sales revenue and (ii) breakout certain cash and cash equivalents into cash and restricted cash line items.

Synutra also previously concluded that certain filings made subsequent to the Form 8-K filed on August 22, 2005, including Synutra's Annual Report on Form 10-K for the fiscal year ended March 31, 2007 and Amendment No. 1 to the Annual Report on Form 10-K for the fiscal year ended March 31, 2007, which presented audited financial statements covering the 12-month periods ended March 31, 2005, 2006, and 2007 (together, the ''Form 10-K"), should have presented, but did not present, audited financial statem
'/>"/>

SOURCE Synutra International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Nasdaq Informs Synutra that the Companys Filing Delinquency has been Cured
2. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
3. Arrow International, Inc. Invites You to Join Its 2007 Annual Meeting of Shareholders on the Web
4. Natural Alternatives International, Inc. Announces Late Filing of its Annual Report on Form 10-K, Revenue for Fiscal 2007 and Guidance on First Quarter of Fiscal 2008
5. Cryo-Cell International, Inc. Reports Third Quarter 2007 Results
6. TenderCare International, Inc. Announces Signing of Merger Agreement with the Hain Celestial Group for All Outstanding Shares of TenderCare Stock
7. Chindex International, Inc. Announces Results for the Quarter and Six Months Ended September 30, 2007
8. DATATRAK International, Inc. Announces 2007 Third Quarter and Nine Month Operating Results
9. Chindex International, Inc. Announces Transfer to NASDAQ Global Market
10. MINRAD International, Inc. Announces Appointment of Charles R. Trego, Jr. to CFO & EVP
11. Z Trim Holdings Reports Restatement of Previously Issued Financial Statements; Amends Bylaws

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...Newswire/--TheBartleHallConventionCenterwilltempor...10,whenKansasCityhoststhelatestinaseriesofmassivef...ceventhasthepotentialtobethebiggestoneyet,becausei...eekdaysinsteadofoveraweekend,"SheriWood,executived...oftheNationalAssociationofFreeClinics(NAFC). ,,...
(Date:11/25/2009)...PRNewswire-USNewswire/--AnarticlebyJanetWoodcock,M...search,titled"ADifficultBalance-PainManagement,Dru...heNewEnglandJournalofMedicine. ,, (Logo: http:/..., Inthearticle,WoodcockdiscussesFDAeffortstostr...oneeditandmanagingtherisksposedbyvariousanalgesics...
(Date:11/25/2009)...e of a statistically significant survival benefit ...gen receptor (ER)-positive tumors had high levels ...alpha S118-P), according to a brief communication ...e National Cancer Institute . , Approximately 50... Preclinical studies have shown that ER-alpha S118...
(Date:11/25/2009)...tion and treatment clinics to resume Monday, Nov. ...vember 25, 2009 -- Centegra Health System is conti...e shots at four Centegra Primary Care (CPC) vaccin...s arrived. The clinics are at CPC sites in Huntley...open as follows: ,   From 4:30 to 7:30...
(Date:11/25/2009)...ewswire-USNewswire/--TheAmericanAssociationforHome...,"S.2128,whichisdesignedtosubstantiallyimprovetool...billwasintroducedbySen.GeorgeLeMieux(R-Fla.). ,...anAssociationforHomecareoutlinedinits13-pointanti-...essinFebruary.Thoseprovisionsincludecallingforreal...
Breaking Medicine News(10 mins):Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2
... Reynolds American,Inc. (NYSE: RAI ) will webcast...d-quarter 2008 financial results on Wednesday, Oct... Time., During the call, members of the Reynolds ...le online on a listen-only basis,at http://www.Re...
... "air burial," grave cairns, funeral mounds, mummi...ces sacred to one culture are often considered "od... example, were fascinated with the historian Herod...ontrary to the Greeks, treatment of their own dead...
...al concerns surrounding use of cells from embryos ...European researchers say they,ve figured out how t...onic-like stem cells. , The findings are the lates...acles associated with their use. , "The ability to...
...The National,Community Pharmacists Association (NC...-term incumbent representing North Carolina, for r... executive vice president and CEO of,NCPA, issued ...serve. That is why the,National Community Pharmaci...
...The National,Community Pharmacists Association (NC...m incumbent representing Arkansas, for re-election... vice president and CEO of NCPA,issued the followi...e National,Community Pharmacists Association stron...
...The National,Community Pharmacists Association (NC...rm incumbent representing Kansas, for re-election ...vice president and CEO of NCPA,issued the followin...National,Community Pharmacists Association strongl...
Other Medicine News:Health News:RAI to Webcast Third-Quarter 2008 Earnings Conference Call 2Health News:Deathways open doors to unexpected cultural practices 2Health News:Researchers Create Embryonic-Like Stem Cells From Human Testes 2Health News:Researchers Create Embryonic-Like Stem Cells From Human Testes 3Health News:Researchers Create Embryonic-Like Stem Cells From Human Testes 4
(Date:11/25/2009)....25/PRNewswire/--SwissrayInternational,Inc.aleadin...ems,announcedtodaythatitsoperationshavebeenacquire...owingSwissray,smedicalimagingbrand.Theacquisitioni...ntractsandinventory.After25yearsofsuccessandgrowth...icaladvancementswithstableandsteadygrowth. ,, "...
(Date:11/25/2009)...ire/--Reportlinker.comannouncesthatanewmarketresea...nagement-GlobalTrends ,, http://www.reportli...html ,, Widespreadavailabilityofgenericdrugs,e...rugshaveacceleratedthepaceofgrowthinthepainmanagem...recontinuetoshapedemandforservices,drugsanddevices...
(Date:11/25/2009)...v.25/PRNewswire/-- ChemoCentryx,Inc.,announcedtod...CT-1(theProspectiveRandomizedOralTherapyEvaluation...npatientswithmoderate-to-severeCrohn,sdiseasedemon...rabilityprofile.Thestudydemonstratedevidenceofclin...edasa70-pointdecreaseintheCrohn,sDiseaseActivityIn...
Breaking Medicine Technology:Swissray International Announces New Ownership 2Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5SXC Health Solutions announces pricing of upsized public offering of common shares 57606 1SXC Health Solutions announces pricing of upsized public offering of common shares 57606 2SXC Health Solutions announces pricing of upsized public offering of common shares 57606 3SXC Health Solutions announces pricing of upsized public offering of common shares 57606 4SXC Health Solutions announces pricing of upsized public offering of common shares 57606 5AstraZeneca Accepts Secretary of Defense Award for Supporting Employees Serving in National Guard and Reserve 57603 1AstraZeneca Accepts Secretary of Defense Award for Supporting Employees Serving in National Guard and Reserve 57603 2Regado Biosciences Announces Allowance in Europe of a Fundamental Patent Broadly Covering Oligonucleotide Modulators to Blood Coagulation Factor Aptam 14136 1Regado Biosciences Announces Allowance in Europe of a Fundamental Patent Broadly Covering Oligonucleotide Modulators to Blood Coagulation Factor Aptam 14136 2Regado Biosciences Announces Allowance in Europe of a Fundamental Patent Broadly Covering Oligonucleotide Modulators to Blood Coagulation Factor Aptam 14136 3
...--Apr 17, 2007 - A 9-month, randomized,double-bli...omparing a 40 mg dose of COPAXONE(R) given daily t...owed a 38 percent greater,reduction in inflammator...ce images (MRI) of the brain. In addition, patient...ean on-trial relapse rate,of 77 percent when compa...
...erican Association for Cancer Research,annual meet...-FirstCall/ --,Medarex, Inc. today presented precl...ity from two separate studies exploring the,effica...ti-CD70,antibody-drug conjugates. CD19 and CD70 ar...jugate approach to cancer therapy. They are,expres...
Other Medicine Technology:Data Published in Neurology Showed That Higher Dose of Copaxone,Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS) 2Data Published in Neurology Showed That Higher Dose of Copaxone,Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS) 3Data Published in Neurology Showed That Higher Dose of Copaxone,Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS) 4Data Published in Neurology Showed That Higher Dose of Copaxone,Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS) 5Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor,Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in,Cancer Animal Models 2Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor,Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in,Cancer Animal Models 3Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor,Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in,Cancer Animal Models 4
MP20
... IntelliVue MP90 is designed to match the pace and...nts. Built on Philips strong heritage in patient m...nt displays has highly flexible screen configurati...-in clinical support tools such as Event Surveilla...
...xNet adds wireless capability to Welch Allyn's com... the Flexible Monitoring concept to provide vital ...o anywhere. FlexNet links multiple devices such as...reless bedside monitors to Acuity® Central Mon...
Spot Vital Signs
Medicine Products: